Annual FCF
-$34.18 M
+$45.64 M+57.18%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual free cash flow is -$34.18 million, with the most recent change of +$45.64 million (+57.18%) on December 31, 2023.
- During the last 3 years, AUPH annual FCF has risen by +$43.02 million (+55.73%).
- AUPH annual FCF is now -2416.49% below its all-time high of -$1.36 million, reached on November 30, 1999.
Performance
AUPH Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$16.90 M
+$1.14 M+7.24%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly free cash flow is $16.90 million, with the most recent change of +$1.14 million (+7.24%) on September 30, 2024.
- Over the past year, AUPH quarterly FCF has increased by +$1.14 million (+7.24%).
- AUPH quarterly FCF is now at all-time high.
Performance
AUPH Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$28.30 M
+$30.10 M+1674.08%
September 30, 2024
Summary
- As of February 7, 2025, AUPH TTM free cash flow is $28.30 million, with the most recent change of +$30.10 million (+1674.08%) on September 30, 2024.
- Over the past year, AUPH TTM FCF has increased by +$30.10 million (+1674.08%).
- AUPH TTM FCF is now at all-time high.
Performance
AUPH TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AUPH Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.2% | +7.2% | +1674.1% |
| 3 y3 years | +55.7% | +209.7% | +124.3% |
| 5 y5 years | +33.9% | +209.7% | +124.3% |
AUPH Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.5% | at high | +136.1% | at high | +117.8% |
| 5 y | 5-year | at high | +78.5% | at high | +130.9% | at high | +117.8% |
| alltime | all time | -2416.5% | +78.5% | at high | +130.9% | at high | +117.8% |
Aurinia Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $16.90 M(+7.2%) | $28.30 M(-1674.1%) |
| Jun 2024 | - | $15.76 M(-184.7%) | -$1.80 M(-91.3%) |
| Mar 2024 | - | -$18.61 M(-230.6%) | -$20.61 M(-39.7%) |
| Dec 2023 | -$34.18 M(-57.2%) | $14.25 M(-208.0%) | -$34.18 M(-10.3%) |
| Sep 2023 | - | -$13.20 M(+332.4%) | -$38.12 M(-5.5%) |
| Jun 2023 | - | -$3.05 M(-90.5%) | -$40.32 M(-38.1%) |
| Mar 2023 | - | -$32.18 M(-411.9%) | -$65.17 M(-18.3%) |
| Dec 2022 | -$79.82 M(-49.9%) | $10.32 M(-167.0%) | -$79.82 M(-31.4%) |
| Sep 2022 | - | -$15.40 M(-44.8%) | -$116.36 M(-17.7%) |
| Jun 2022 | - | -$27.91 M(-40.4%) | -$141.37 M(-6.6%) |
| Mar 2022 | - | -$46.83 M(+78.6%) | -$151.30 M(-5.0%) |
| Dec 2021 | -$159.19 M(+106.2%) | -$26.23 M(-35.1%) | -$159.19 M(+20.6%) |
| Sep 2021 | - | -$40.41 M(+6.8%) | -$131.95 M(+6.2%) |
| Jun 2021 | - | -$37.84 M(-30.9%) | -$124.23 M(+13.9%) |
| Mar 2021 | - | -$54.72 M(-5459.6%) | -$109.10 M(+41.3%) |
| Dec 2020 | -$77.20 M(+21.2%) | $1.02 M(-103.1%) | -$77.20 M(-25.5%) |
| Sep 2020 | - | -$32.70 M(+44.0%) | -$103.66 M(+25.2%) |
| Jun 2020 | - | -$22.71 M(-0.5%) | -$82.77 M(+12.9%) |
| Mar 2020 | - | -$22.82 M(-10.3%) | -$73.34 M(+15.2%) |
| Dec 2019 | -$63.69 M(+23.2%) | -$25.44 M(+115.5%) | -$63.69 M(+22.7%) |
| Sep 2019 | - | -$11.80 M(-11.1%) | -$51.88 M(+0.9%) |
| Jun 2019 | - | -$13.28 M(+0.8%) | -$51.41 M(+1.9%) |
| Mar 2019 | - | -$13.17 M(-3.4%) | -$50.45 M(-2.4%) |
| Dec 2018 | -$51.69 M(+25.5%) | -$13.64 M(+20.4%) | -$51.69 M(+10.0%) |
| Sep 2018 | - | -$11.33 M(-8.1%) | -$46.99 M(+6.3%) |
| Jun 2018 | - | -$12.32 M(-14.5%) | -$44.19 M(-3.7%) |
| Mar 2018 | - | -$14.40 M(+61.1%) | -$45.88 M(+11.4%) |
| Dec 2017 | -$41.19 M(+119.8%) | -$8.94 M(+4.9%) | -$41.19 M(+12.8%) |
| Sep 2017 | - | -$8.53 M(-39.2%) | -$36.53 M(+13.5%) |
| Jun 2017 | - | -$14.01 M(+44.2%) | -$32.20 M(+38.6%) |
| Mar 2017 | - | -$9.72 M(+127.2%) | -$23.24 M(+24.0%) |
| Dec 2016 | -$18.74 M(+5.2%) | -$4.28 M(+2.0%) | -$18.74 M(-2.9%) |
| Sep 2016 | - | -$4.19 M(-17.0%) | -$19.30 M(-5.1%) |
| Jun 2016 | - | -$5.05 M(-3.3%) | -$20.33 M(+7.0%) |
| Mar 2016 | - | -$5.22 M(+7.9%) | -$19.00 M(+6.7%) |
| Dec 2015 | -$17.82 M(+4.8%) | -$4.84 M(-7.4%) | -$17.82 M(+9.0%) |
| Sep 2015 | - | -$5.23 M(+40.5%) | -$16.35 M(+7.8%) |
| Jun 2015 | - | -$3.72 M(-7.8%) | -$15.16 M(-3.3%) |
| Mar 2015 | - | -$4.03 M(+19.7%) | -$15.68 M(-7.8%) |
| Dec 2014 | -$17.00 M(+259.5%) | -$3.37 M(-16.7%) | -$17.00 M(+4.9%) |
| Sep 2014 | - | -$4.04 M(-4.4%) | -$16.20 M(+18.5%) |
| Jun 2014 | - | -$4.23 M(-21.0%) | -$13.68 M(+38.5%) |
| Mar 2014 | - | -$5.36 M(+108.2%) | -$9.88 M(+108.9%) |
| Dec 2013 | -$4.73 M(-28.2%) | -$2.57 M(+69.1%) | -$4.73 M(+60.6%) |
| Sep 2013 | - | -$1.52 M(+255.4%) | -$2.94 M(+9.9%) |
| Jun 2013 | - | -$428.00 K(+106.8%) | -$2.68 M(-46.1%) |
| Mar 2013 | - | -$207.00 K(-73.8%) | -$4.97 M(-24.5%) |
| Dec 2012 | -$6.59 M(+162.8%) | -$788.70 K(-37.2%) | -$6.59 M(-7.6%) |
| Sep 2012 | - | -$1.25 M(-53.9%) | -$7.12 M(+1.4%) |
| Jun 2012 | - | -$2.72 M(+49.6%) | -$7.03 M(+20.6%) |
| Mar 2012 | - | -$1.82 M(+37.2%) | -$5.83 M(+132.5%) |
| Dec 2011 | -$2.51 M | -$1.33 M(+14.4%) | -$2.51 M(+27.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$1.16 M(-23.7%) | -$1.96 M(-17.7%) |
| Jun 2011 | - | -$1.52 M(-201.3%) | -$2.38 M(+35.7%) |
| Mar 2011 | - | $1.50 M(-292.2%) | -$1.76 M(-62.4%) |
| Dec 2010 | -$4.67 M(-56.3%) | -$780.90 K(-50.6%) | -$4.67 M(-14.3%) |
| Sep 2010 | - | -$1.58 M(+76.7%) | -$5.45 M(-0.9%) |
| Jun 2010 | - | -$894.60 K(-36.6%) | -$5.49 M(-38.0%) |
| Mar 2010 | - | -$1.41 M(-9.5%) | -$8.86 M(-17.1%) |
| Dec 2009 | -$10.69 M(-39.7%) | -$1.56 M(-4.3%) | -$10.69 M(+0.5%) |
| Sep 2009 | - | -$1.63 M(-61.7%) | -$10.63 M(-3.3%) |
| Jun 2009 | - | -$4.26 M(+31.3%) | -$11.00 M(+0.3%) |
| Mar 2009 | - | -$3.24 M(+115.4%) | -$10.97 M(-38.1%) |
| Dec 2008 | -$17.73 M(-39.6%) | -$1.51 M(-24.5%) | -$17.73 M(-22.0%) |
| Sep 2008 | - | -$1.99 M(-52.8%) | -$22.73 M(-25.2%) |
| Jun 2008 | - | -$4.23 M(-57.7%) | -$30.37 M(-8.2%) |
| Mar 2008 | - | -$10.00 M(+53.7%) | -$33.08 M(+12.8%) |
| Dec 2007 | -$29.33 M(+31.8%) | -$6.51 M(-32.5%) | -$29.33 M(+2.9%) |
| Sep 2007 | - | -$9.64 M(+38.9%) | -$28.49 M(+18.9%) |
| Jun 2007 | - | -$6.94 M(+11.1%) | -$23.97 M(+10.1%) |
| Mar 2007 | - | -$6.24 M(+10.2%) | -$21.78 M(-2.1%) |
| Dec 2006 | -$22.25 M(+1.3%) | -$5.67 M(+10.7%) | -$22.25 M(+0.3%) |
| Sep 2006 | - | -$5.12 M(+7.8%) | -$22.18 M(+7.6%) |
| Jun 2006 | - | -$4.75 M(-29.3%) | -$20.61 M(-5.5%) |
| Mar 2006 | - | -$6.72 M(+20.0%) | -$21.80 M(-0.7%) |
| Dec 2005 | -$21.96 M(+4.5%) | -$5.60 M(+58.0%) | -$21.96 M(-7.4%) |
| Sep 2005 | - | -$3.54 M(-40.4%) | -$23.72 M(-9.4%) |
| Jun 2005 | - | -$5.94 M(-13.6%) | -$26.20 M(+5.7%) |
| Mar 2005 | - | -$6.88 M(-6.6%) | -$24.79 M(+17.9%) |
| Dec 2004 | -$21.02 M(+184.3%) | -$7.36 M(+22.4%) | -$21.02 M(+40.7%) |
| Sep 2004 | - | -$6.02 M(+32.5%) | -$14.94 M(-7.2%) |
| Jun 2004 | - | -$4.54 M(+46.3%) | -$16.10 M(+149.1%) |
| Mar 2004 | - | -$3.10 M(+143.4%) | -$6.46 M(-12.6%) |
| Dec 2003 | -$7.39 M(+38.1%) | -$1.28 M(-82.2%) | -$7.39 M(-31.7%) |
| Sep 2003 | - | -$7.18 M(-240.9%) | -$10.82 M(+1257.9%) |
| Jun 2003 | - | $5.09 M(-226.2%) | -$796.80 K(-86.1%) |
| Mar 2003 | - | -$4.04 M(-14.1%) | -$5.74 M(+7.3%) |
| Dec 2002 | -$5.35 M(-33.3%) | -$4.70 M(-265.1%) | -$5.35 M(+720.9%) |
| Sep 2002 | - | $2.85 M(+1833.9%) | -$652.10 K(-80.8%) |
| Jun 2002 | - | $147.20 K(-104.0%) | -$3.40 M(-46.4%) |
| Mar 2002 | - | -$3.65 M(-3622.7%) | -$6.34 M(-20.1%) |
| Dec 2001 | -$8.02 M(+25.9%) | - | - |
| Aug 2001 | - | $103.50 K(-103.7%) | -$7.93 M(-16.4%) |
| May 2001 | - | -$2.79 M(-4.5%) | -$9.48 M(+16.8%) |
| Feb 2001 | - | -$2.92 M(+26.4%) | -$8.12 M(+27.5%) |
| Nov 2000 | -$6.37 M(+368.9%) | -$2.31 M(+59.3%) | -$6.37 M(+38.1%) |
| Aug 2000 | - | -$1.45 M(+1.5%) | -$4.61 M(+40.4%) |
| May 2000 | - | -$1.43 M(+22.2%) | -$3.28 M(+26.5%) |
| Feb 2000 | - | -$1.17 M(+111.0%) | -$2.60 M(+91.1%) |
| Nov 1999 | -$1.36 M(-28.1%) | -$555.30 K(+345.3%) | -$1.36 M(+69.2%) |
| Aug 1999 | - | -$124.70 K(-83.3%) | -$802.90 K(+18.4%) |
| May 1999 | - | -$744.50 K(-1222.9%) | -$678.20 K(-1122.9%) |
| Feb 1999 | - | $66.30 K | $66.30 K |
| Nov 1998 | -$1.89 M | - | - |
FAQ
- What is Aurinia Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual FCF year-on-year change?
- What is Aurinia Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly FCF year-on-year change?
- What is Aurinia Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals TTM FCF year-on-year change?
What is Aurinia Pharmaceuticals annual free cash flow?
The current annual FCF of AUPH is -$34.18 M
What is the all time high annual FCF for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual free cash flow is -$1.36 M
What is Aurinia Pharmaceuticals annual FCF year-on-year change?
Over the past year, AUPH annual free cash flow has changed by +$45.64 M (+57.18%)
What is Aurinia Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of AUPH is $16.90 M
What is the all time high quarterly FCF for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly free cash flow is $16.90 M
What is Aurinia Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, AUPH quarterly free cash flow has changed by +$1.14 M (+7.24%)
What is Aurinia Pharmaceuticals TTM free cash flow?
The current TTM FCF of AUPH is $28.30 M
What is the all time high TTM FCF for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high TTM free cash flow is $28.30 M
What is Aurinia Pharmaceuticals TTM FCF year-on-year change?
Over the past year, AUPH TTM free cash flow has changed by +$30.10 M (+1674.08%)